LINC01544

Across TCGA pan-cancer cohorts, LINC01544 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC01544 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC01544 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01544 expression acts as an unfavorable survival marker, although some lineages such as LUAD and KIRC show a favorable association.

LUAD, LIHC, and ACC are the cancer types where LINC01544 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	III,IV	0.912	0.391	.002	60	view →
LIHC	OS	Tertile	All	0.666	0.804	.002	45	view →
ACC	OS	Tertile	All	0.133	0.686	.004	45	view →
BLCA	DFS	Tertile	IV	0.295	0.554	<.001	36	view →
DLBC	OS	Quartile	II,III,IV	0.257	1.000	.002	33	view →
KIRC	DFS	Quartile	All	0.885	0.479	<.001	28	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
THYM	OS	Tertile	All	0.843	0.985	.018	15	view →
UCS	DFS	Tertile	IV	0.996	0.554	.018	12	view →
BRCA	DFS	Tertile	II,III,IV	0.417	0.565	.006	10	view →
SKCM	DFS	Tertile	All	0.332	0.181	.022	9	view →
UVM	OS	Tertile	III,IV	0.136	0.874	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC01544–LUAD (DFS)

Open the LUAD breakdown →